Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging

Journal Article · · Toxicology and Applied Pharmacology
 [1]; ; ; ; ;  [1];  [2]; ;  [3];  [1]
  1. Division of Toxicologic Pathology, Department of Toxicological Research, National Institute of Toxicological Research, Korea Food and Drug Administration, 231 Jinhoungno Eunpyung-ku, Seoul 122-704 (Korea, Republic of)
  2. Division of Genetic Toxicology, Department of Toxicological Research, National Institute of Toxicological Research, Korea Food and Drug Administration, 231 Jinhoungno Eunpyung-ku, Seoul 122-704 (Korea, Republic of)
  3. Research Center for Biomolecular Nanotechnology, Department of Life Science, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Buk-gu, Gwangju 500-712 (Korea, Republic of)
Recent advances in the development of nanotechnology and devices now make it possible to accurately deliver drugs or genes to the lung. Magnetic nanoparticles can be used as contrast agents, thermal therapy for cancer, and be made to concentrate to target sites through an external magnetic field. However, these advantages may also become problematic when taking into account safety and toxicological factors. This study demonstrated the pulmonary toxicity and kinetic profile of anti-biofouling polymer coated, Cy5.5-conjugated thermally cross-linked superparamagnetic iron oxide nanoparticles (TCL-SPION) by optical imaging. Negatively charged, 36 nm-sized, Cy5.5-conjugated TCL-SPION was prepared for optical imaging probe. Cy5.5-conjugated TCL-SPION was intratracheally instilled into the lung by a non-surgical method. Cy5.5-conjugated TCL-SPION slightly induced pulmonary inflammation. The instilled nanoparticles were distributed mainly in the lung and excreted in the urine via glomerular filtration. Urinary excretion was peaked at 3 h after instillation. No toxicity was found under the concentration of 1.8 mg/kg and the half-lives of nanoparticles in the lung and urine were estimated to be about 14.4 {+-} 0.54 h and 24.7 {+-} 1.02 h, respectively. Although further studies are required, our results showed that Cy5.5-conjugated TCL-SPION can be a good candidate for use in pulmonary delivery vehicles and diagnostic probes.
OSTI ID:
21272633
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 1 Vol. 239; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

TRANSLOCATION AND EXCRETION OF PULMONARY DEPOSITED PLUTONIUM OXIDE
Technical Report · Fri Aug 01 00:00:00 EDT 1958 · OSTI ID:4299061

Rapid solubilization and translocation of /sup 109/CdO following pulmonary deposition. [Rats]
Journal Article · Mon Dec 31 23:00:00 EST 1979 · Toxicol. Appl. Pharmacol.; (United States) · OSTI ID:5791516

Pulmonary fate of (/sup 3/H)bleomycin A2 in mice
Journal Article · Sat Dec 31 23:00:00 EST 1983 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:6728593